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Genetic testing of children for adult-onset conditions:
opinions of the British adult population and
implications for clinical practice
Shiri Shkedi-Raﬁd*,1, Angela Fenwick1, Sandi Dheensa1 and Anneke M Lucassen1
This study set out to explore the attitudes of a representative sample of the British public towards genetic testing in children to
predict disease in the future. We sought opinions about genetic testing for adult-onset conditions for which no prevention/
treatment is available during childhood, and about genetic ‘carrier’ status to assess future reproductive risks. The study also
examined participants’ level of agreement with the reasons professional organisations give in favour of deferring such testing.
Participants (n=2998) completed a specially designed questionnaire, distributed by email. Nearly half of the sample (47%)
agreed that parents should be able to test their child for adult-onset conditions, even if there is no treatment or prevention at
time of testing. This runs contrary to professional guidance about genetic testing in children. Testing for carrier status was
supported by a larger proportion (60%). A child’s future ability to decide for her/himself if and when to be tested was the least
supported argument in favour of deferring testing.
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INTRODUCTION
Professional organisations worldwide are largely unanimous in their
recommendation to defer the genetic testing of children for conditions
they may develop in the future.1–3 Most suggest that such testing
should only take place in childhood if prevention or treatment is
available at the time of testing that may alter the future outcome of the
condition. Otherwise, testing should be postponed until such time that
there is medical beneﬁt or until the child is old enough to make a
decision for themselves. Recommendations about genetic testing to see
whether someone is a ‘carrier’ for a recessive condition or a balanced
chromosomal rearrangement are similar: where such carrier status
(hereafter called testing for reproductive risks) confers no present or
future health problems for the child, but instead possible risks for their
children, testing should be postponed in childhood.1,2,4,5
Evidence from clinicians in the United Kingdom, the United States
and Australia suggests, however, that parents still regularly request
testing of their children sometimes years before a medical intervention
might be offered.6,7
To the best of our knowledge, only one study has looked at the
general public’s views on childhood genetic testing for adult-onset
conditions, and this was undertaken when genetic testing for future
risks was still largely a hypothetical rather than practical possibility.
Using a survey distributed to 1000 adults in the United States, in the
mid-90s, Wertz and Fletcher8 demonstrated that just over half of the
respondents (53%) agreed that parents should be able to test their
minor children for conditions that were ‘neither preventable nor
treatable’.
The ﬁeld of genetics has progressed considerably in the subsequent
two decades, with many more genetic tests now routinely available
than when Wertz et al undertook their survey. Professional guidance
abounds, yet members of the public are those who may ask for testing,
live with its consequences or support other family members/friends
who have genetic conditions. It is, therefore, important to ascertain
their opinions and explore the extent to which they agree/disagree
with some of the arguments for deferring genetic testing until
adulthood that the guidelines espouse. Better understanding could
also improve communication between health care professionals
(HCPs) and those referred to genetic services and allow any
discrepancies between public expectations and professional guidance
to be addressed. Furthermore, as genetic testing is likely to be
increasingly ‘mainstreamed’ into all clinical specialities,9 assessing
public expectations is timely.
This paper, which is part of a larger study exploring the views of
various stakeholders about childhood genetic testing for adult-onset
conditions, reports on the opinions of a representative sample of the
adult British population about such testing. It examines the implica-
tions of these views for clinical practice in Britain.
MATERIALS AND METHODS
The study protocol was approved by the University of Southampton, Faculty of
Medicine Ethics Committee.
Participants
An online survey was conducted in April 2013 via YouGov, an independent
research company conducting online surveys.10 YouGov has a registered panel
of over 3.3 million people worldwide, including over 350 000 British adults,
chosen on the basis that their sociodemographic characteristics represent the
British population. A representative sub-population of the panel members
(n= 3109) was sent an email containing a link to the questionnaire. On
completion, participants earned 50 points, which were redeemable for rewards
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(for example, for 5000 points, panellists can claim a reward of £50 or a variety
of other prizes).
Questionnaire
A structured questionnaire was designed for this study based on current
literature and guidelines on childhood genetic testing.2 It was reviewed for
accuracy, ﬂow and organisation by experts in survey design, genetics, social
sciences, philosophy and ethics and by lay and support group representatives.
Pilot testing was conducted with 35 individuals of different ages and
professional backgrounds, from lay to healthcare professionals. They were
asked for their understanding of the questions. While revising the questions,
more notice was given to comments made by lay people.
Here we report on respondents’ level of agreement/disagreement (strongly
agree, agree, neither agree nor disagree, disagree, strongly disagree and don’t
know) with whether parents should be able to test their children for (1) adult-
onset conditions for which there is no current treatment/care and (2) testing for
reproductive risks. We also present respondents’ views on four arguments in
favour of deferring childhood genetic testing (detailed in Table 1), which are
utilised in professional guidance. For the full questionnaire, see Supplementary
Information.
Sociodemographic data were collected on respondents’ gender, age, socio-
economic status and place of residence.
Data analysis
Analyses were performed using the IBM Statistical Package for the Social
Sciences (SPSS) v. 20 (IBM software UK). Descriptive statistics were used to
conduct the majority of the analyses. Missing data were excluded from the
analysis. Pearson’s χ2-test was used to assess the associations between
demographic variables and respondent attitudes. For a parsimonious analysis,
the strongly agree and agree responses were grouped together, as well as the
strongly disagree and disagree. ‘Neither agree nor disagree’ and ‘don’t know’
responses were also grouped together, hereafter referred to as 'uncertain'.
Socioeconomic status categories A, B and C1 were grouped together, as were
C2, D and E. Respondents’ answers to reasons for deferring testing, listed in
Table 1, were ranked so that 0 represents respondents who chose ‘don’t know’;
1 represents those who thought that the reasons given were not good ones to
delay testing; and 2 represents those who thought that they were good reasons
to delay testing. Items were then summed to provide each respondent with an
overall score (scale score). This score could range from 0, for those who chose
‘don’t know’ for all four statements, to 8, for those who thought that all four
statements were good reasons to delay testing.
For ease of presentation, percentages are rounded to the nearest whole
number. A two sided Po0.05 was considered statistically signiﬁcant.
RESULTS
Survey respondents
Traditional response rates are not measured in internet surveys.11
Instead, an active sampling process is carried out from panellists
already signed up to take part in such surveys. Of the 3109 panellists
who were approached, 2998 (96%) completed the survey. Participants’
demographic characteristics are presented in Table 2.
Opinions on predictive genetic testing in childhood
Testing for adult-onset conditions that the child may develop in the
future. As demonstrated in Figure 1, nearly half of the respondents
(47%, n= 1423) agreed that parents should be allowed to test their
children for adult-onset conditions, even if the child would not need
any particular treatment or care before adulthood. About a third of the
sample (33%, n= 979) were uncertain about such testing. Only a ﬁfth
of the sample (20%, n= 596) disagreed that parents should be able to
test their children for such conditions and it is interesting to note that
this opinion is the one most in line with professional guidance.
Testing for reproductive risks. The majority of the sample (60%,
n= 1799) agreed that parents should be able to test their child for
reproductive risks. About a quarter of the sample (26%, n= 785) were
uncertain. Fourteen percent of respondents (n= 413) disagreed that
parents should be allowed to have such tests, in line with professional
guidance.
The associations between views about testing and demographic variables.
Age was associated with respondents’ opinions about the two types of
testing, but in different ways. Younger respondents (aged 18–29) were
more likely to support testing for adult-onset conditions with no
treatment/care in childhood (P= 0.005). The association between age
and opinions about testing for reproductive risks was the other way
round, as older respondents (40 and above) were signiﬁcantly more
likely to support such testing in comparison with younger (o40)
respondents (Po0.001).
Opinions were also signiﬁcantly associated with respondents’ gender.
Men were more likely than women to support testing for adult-onset
conditions with no treatment/care in childhood (54 vs 41%, Po0.001)
and testing for reproductive risks (64 vs 57%, Po0.001).
Opinions about testing for adult-onset conditions with no treat-
ment/care in childhood were also associated with socioeconomic
status. Respondents in the group category C2DE (broadly manual
occupations and ‘working class’) were more likely to be uncertain,
compared with respondents in category ABC1 (broadly professional
occupations and ‘middle class’; 36 vs 30%, P= 0.005).
Opinions on arguments in favour of deferring childhood testing for
adult-onset conditions
Table 1 demonstrates respondents’ opinions on four arguments in
favour of deferring testing for adult-onset conditions.
Removing the child’s future ability to make their own decisions was
a less supported reason (supported by about a third of respondents).
Respondents’ opinions on the other three statements were similar, with
nearly half opining that these were good reasons to delay testing (45, 45
and 46%, respectively). About a quarter of the sample was uncertain
whether or not the four arguments were good reasons to delay testing
(25, 24, 25 and 25%, respectively). Looking at respondents’ scale scores,
502/2998 respondents (17%) had a score of 0, that is, answered ‘don’t
know’ to all four statements. Twenty-one percent of the sample
(637/2998) had a scale score of 8, that is, thought all four arguments
were good reasons to delay testing. Respondents with a scale of 4
(569/2998 respondents, 19%) could have thought that all four
arguments were not good reasons to delay testing, but could also have
Table 1 Opinions on arguments in favour of deferring testing for adult-onset conditions
Are these good reasons to delay testing? A good reason Not a good reason Not sure
It removes the child’s ability to decide when they are older if they want to be tested or not 37%, n=1103 38%, n=1129 25%, n=765
The result may make the child feel stigmatised or discriminated against as they grow up 45%, n=1342 31%, n=925 24%, n=731
The child may be misinformed about the condition they might develop if they are not involved
in the decision about testing
45%, n=1343 30%, n=893 25%, n=762
There is no medical beneﬁt to testing now; the test should only be done when there is beneﬁt 46%, n=1366 29%, n=886 25%, n=746
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given a range of answers for the different statements. The remainder of
the sample (43%) had a scale score other than 0, 4 and 8, which would
suggest that they gave a range of answers to the various statements.
The associations between views about the arguments in favour of deferring
testing and demographic variables. Age was signiﬁcantly associated
with respondents’ opinions about the four arguments (P= 0.004,
0.023, 0.008 and 0.000, respectively). Respondents over the age of 60
were more likely to think that removing the child’s ability to decide
when they are older if they want to be tested (statement 1, Table 1)
was not a good reason to delay testing. Respondents aged 25–39 were
more likely to think that the fear of stigmatisation/discrimination
(statement 2) and potentially misinforming the child about the test
results when older (statement 3) were good reasons to delay testing.
Younger respondents (aged 18–24) were least likely to think that
statement 4 was a good reason to delay testing (that is, testing should
only be done when there is medical beneﬁt).
Women were signiﬁcantly more likely than men to think that all
four statements were good reasons to delay testing (Po0.001 for all
statements).
Socioeconomic status was also signiﬁcantly associated with respon-
dents’ opinions about the four statements, but in different ways.
‘Working class’ respondents were more likely to be uncertain about
statements 1 and 3 (Po0.001 in both cases). ‘Middle class’ respon-
dents were more likely to think that the fear of stigmatisation/
discrimination and the lack of medical beneﬁt (statements 2 and 4)
were good reasons to delay testing (Po0.001 in both).
Associations between respondents’ attitudes towards childhood
testing for adult-onset conditions and their opinions on arguments
in favour of deferring such testing
A correlation was found between respondents’ attitudes towards
allowing parents to test their children for adult-onset conditions with
no current medical utility, and their opinions about each of the
various statements. More speciﬁcally, those who supported testing
were more likely to think that these were not good reasons to defer
testing (60, 51, 48 and 50%, respectively, in the order detailed in
Table 1, Po0.001); those who objected to testing were more likely to
agree that these were good reasons to delay testing (70, 78, 74 and
82%, respectively, Po0.001); and those who were uncertain about
testing were most likely to remain uncertain about arguments in
favour of delaying testing (49, 46, 46 and 46%, respectively, Po0.001).
DISCUSSION
Our survey was designed to gain an insight into the reactions of a
representative sample of the adult British population to the issue
of genetic testing in children for adult-onset conditions and
reproductive risks.
Our ﬁndings show that 47% of the sample agreed that parents
should be able to test their children for adult-onset conditions with no
treatment/care at the time of testing, even if (at least some of them)
agreed that there are good reasons to delay such testing. This ﬁnding is
consistent with our current clinical experience and national profes-
sional discussions such as the Genethics forum,6 where clinicians
report that parents regularly request such testing and that they are
unsure how to deal with these in the face of professional guidance.
Testing for reproductive risks was supported by 60% of the sample,
representing a greater proportion than those who supported predictive
testing for conditions that the child herself may develop in the future.
We ﬁnd this difference interesting as, in both cases, there is no medical
beneﬁt to knowing the result before the child can make up their own
mind if and when to be tested. Interestingly, in its response to the
1994 report of the UK Clinical Genetics Society on childhood genetic
testing, the Genetic Interest Group (now Genetic Alliance UK), an
umbrella organisation for patient organisations supporting individuals
affected by genetic conditions in the United Kingdom, distinguished
testing for reproductive risks and testing for adult-onset conditions.12
Testing for reproductive risks was considered ‘less serious’,12 with
potential beneﬁts (for example, gradual adaptation to the informa-
tion).12,13 Our ﬁndings suggest that participants saw knowledge as
beneﬁcial in and of itself.
There are a number of potential explanations why nearly half of our
respondents supported genetic testing for adult-onset conditions and
47% 20% 33%
60% 26%14%
 Parents should be
able to test their
young child to see
what condition s/he
may develop in the
future, even if the
child would not need
any particular
treatment or care
until they are an
adult
 Parents should be
 able to test their 
young child to tell if 
they are a carrier of a 
genetic condition
Agree Disagree Uncertain 
Figure 1 Opinions on testing children for adult-onset conditions with no
treatment or care in childhood and testing for reproductive risks. (a) Parents
should be able to test their young child to see what condition s/he may
develop in the future, even if the child would not need any particular
treatment or care until they are adults. (b) Parents should be able to test
their young child to tell if they are a carrier of a genetic condition.
Table 2 Characteristics of participants
Participants, n (%) Characteristic
Age
363 (12) 18–24
764 (25) 25–39
1025 (34) 40–59
845 (28) 460
Gender
1541 (51) Female
1457 (49) Male
Social gradea
1709 (57) ABC1
1289 (43) C2DE
Place of residence
384 (13) London
738 (25) Rest of South
642 (21) Midlands/Wales
974 (32) North
261 (9) Scotland
aThe socioeconomic classiﬁcation used by YouGov is derived from the National Readership
Survey (NRS): ABC1 represents people who are employed in professional occupations (broadly
‘middle class’); C2DE represents manual workers and those on subsistence levels of income who
may or may not be employed (broadly ‘working class’).
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over half supported testing for reproductive risks. One possible
explanation is that, although there are no known interventions, people
may believe that parents can do something with the information, such
as change their child’s diet, be alert to new interventions, prepare their
children and themselves for symptom onset, encourage children who
are carriers to adopt various lifestyle practices and inform them of their
possibly increased reproductive risks before they have children.13–15
It could also be that the big drive for personalised medicine and
media coverage of the achievements in the ﬁeld of genetics have
resulted in the general impression that genetic testing is mainly
beneﬁcial, with few downsides or limitations.16 At a time when
genetic/genomic testing is becoming cheaper and more accessible in
both healthcare and direct-to-consumer settings, people may not
appreciate that the technical ease of obtaining a result will not always
reﬂect the difﬁculties in interpreting and incorporating the results into
daily life, nor that there may be disadvantages to certain types of
testing. It has been previously demonstrated that people often do not
fully appreciate the complexity of the consequences of genetic testing
until they receive their results.17,18
Another potential explanation of respondents’ general support of
childhood testing is that they support parental ‘rights’ to decide
whether or not to test their children, even if they recognise that there
are good reasons to delay testing.13,19–21 This may also explain why the
ability of the future child to decide for themselves if and when to be
tested was the least supported argument for deferring testing (Table 1).
Previous research has showed that healthy adults who were tested in
childhood for X-linked and autosomal-recessive conditions, or
balanced chromosomal rearrangements, largely felt that the decision
to test a child should be made by the parents.22–24 Yet, the importance
that is attributed by HCPs to the preservation of future decision-
making ability has been repeatedly reiterated in empirical studies
looking at HCPs’ views on childhood testing.7,8,25 The inclination to
protect future autonomy may explain why HCPs are more willing to
approve testing for adult-onset conditions in older minors as opposed
to younger ones, even if there are still many years before the predicted
onset of the condition in question.7
Whereas HCPs focus on medical beneﬁt to the child, public
concepts of children’s interests may be much broader, which may
make it harder for HCPs to convey the potential beneﬁt of allowing
the child to decide for themselves in the future if and when to be
tested for conditions with no treatment/care in childhood. Our
ﬁndings suggest that people may relate more easily to other reasons
to defer testing, such as the fear of discrimination and stigmatisation,
the lack of medical utility and the possibility of misinforming the child
in the future about their test results.
With the likely ‘mainstreaming’ of genetics, it might be that (in the
UK as well as in other countries) HCPs outside the specialty of clinical
genetics will discuss childhood genetic testing with parents with
possibly less time for detailed discussions. Media coverage of highly
unusual cases (for example, http://www.bbc.co.uk/news/uk-england-
stoke-staffordshire-27832039) might also prompt parents to request
testing for their children at younger ages. The potential gap between
parents’ and HCPs’ understandings of what genetic testing will tell
them about their children’s futures may, therefore, be difﬁcult to
bridge. We suggest that wider public engagement exercises are
designed that may help towards a greater concordance between public
and professional views.
This study has some limitations: we did not collect data on the
parental status of respondents, offspring ages and respondents’ prior
knowledge of genetics. Although it might have been interesting to see
if parental status inﬂuenced people’s views about predictive genetic
testing in childhood, this was not what we set out to do. We cannot
rule out the possibility that better understanding of various aspects of
testing and parental status would inﬂuence opinions. However, a large
proportion of respondents did not have clear opinions about the
various types of testing, which is likely to reﬂect a lack of prior
knowledge about the issues.
As this survey was used to provide general trends and associations,
categories with multiple options (such as Likert scale with more than
three options and demographics with more than two to three groups)
were grouped together (such as degree of agreement/disagreement,
socioeconomic status). A more detailed analysis might have better
identiﬁed subgroups within the respondents that were more likely to
request childhood testing, and disagree with the reasons brought
forward by professional guidelines to delay testing. For most of the
respondents, we expect these questions were hypothetical, in that they
would not actually have sought genetic testing of their children.
Previous research, mainly on predictive testing for Huntington’s
disease, demonstrated that such hypothetical decisions do not
necessarily represent actual behaviour.26,27 Nevertheless, even if our
results do not represent the actual decisions parents would make
regarding testing of their children, they give an indication about how
they might feel, at least initially, were the situation to become a reality
for them. This information could be incorporated into consultations
by HCPs.
With regards to respondents’ answers to the four statements in
favour of deferring testing (Table 1), it could be that at least some of
the respondents chose the same answer (good reason/not good reason/
don’t know) for all statements. These participants might have been
overall in favour or not in favour of childhood testing and answered
accordingly, regardless of the reason provided. Alternatively, partici-
pants might not have thought carefully about the differences between
the statements. However, at least 43% of participants gave different
answers for each reason. Another interesting question, beyond the
scope of the current study, is whether respondents’ views would have
been different if they were asked about testing minors for severe and
untreatable adult-onset conditions, especially if they were provided
with information about the uptake of such tests by at-risk adults.
In summary, our study shows that the British adult public is more
likely to either be uncertain or in support of childhood testing for
adult-onset conditions for which there is no intervention at the time of
testing. Testing to assess future reproductive risks is also supported.
Only a minority of participants agreed with HCPs’ attitudes and
professional guidelines about delaying such testing until it is medically
actionable, or until the child is old enough to make a decision for
themselves. Whereas HCPs think that preservation of future autonomy
is an important reason to defer testing, our respondents were more
likely to think that this was not a good reason, or to remain uncertain.
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